【结 构 式】 |
【药物名称】 【化学名称】N1,N4-Bis[3-oxo-3-(9H-purin-6-ylsulfanylmethoxy)propyl]-N2-[2-(polyethyleneglycol)ethoxycarbonyl]-L-asparaginamide 【CA登记号】 【 分 子 式 】C27H32N11O9S2 【 分 子 量 】718.75239 |
【开发单位】Enzon (Originator) 【药理作用】Chemical Delivery Systems, DRUG DELIVERY, Drug Delivery Systems, ONCOLYTIC DRUGS |
合成路线1
Treatment of N-Boc-beta-alanine (I) with bromochloromethane gives the chloromethyl ester (II), which is further converted to the iodomethyl analogue (III) under the Finkelstein halide exchange reaction conditions. Condensation of iodomethyl ester (III) with 6-mercaptopurine (IV) provides adduct (V). The N-Boc group of (V) is then removed employing trifluoroacetic acid to furnish the amine compound (VI). Finally, EDC-mediated coupling of amine (VI) with the polyethyleneglycol-bound aspartic acid (VII) affords the title mercaptopurine prodrug.
【1】 Choe, Y.H.; et al.; PEG prodrugs of 6-mercaptopurine (6-MP) - I: Synthesis and in vitro studies. Proc Am Assoc Cancer Res 2002, 43. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26616 | N-(tert-butoxycarbonyl)-beta-alanine | 3303-84-2 | C8H15NO4 | 详情 | 详情 |
(II) | 57758 | chloromethyl 3-[(tert-butoxycarbonyl)amino]propanoate | C9H16ClNO4 | 详情 | 详情 | |
(III) | 57759 | iodomethyl 3-[(tert-butoxycarbonyl)amino]propanoate | C9H16INO4 | 详情 | 详情 | |
(IV) | 11711 | 9H-Purine-6-thiol; 9H-Purin-6-ylhydrosulfide; 6-Mercaptopurine | 50-44-2 | C5H4N4S | 详情 | 详情 |
(V) | 57760 | (9H-purin-6-ylsulfanyl)methyl 3-[(tert-butoxycarbonyl)amino]propanoate | C14H19N5O4S | 详情 | 详情 | |
(VI) | 57761 | (9H-purin-6-ylsulfanyl)methyl 3-aminopropanoate | C9H11N5O2S | 详情 | 详情 | |
(VII) | 65174 | C9H14NO7 | 详情 | 详情 |